The Centers for Medicare & Medicaid Services (CMS) publishes the Provider Utilization and Payment Data: Referring Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Public Use File referred here as “Referring Provider DMEPOS PUF” in efforts to make the healthcare system more transparent, affordable, and accountable.

description:

This dataset, which is part of CMSs Medicare Provider Utilization and Payment Data, details information on Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) products and services provided to Medicare beneficiaries via referrals through physicians and other healthcare professionals. This data covers 2013 and 2014.

This dataset, which is part of CMSs Medicare Provider Utilization and Payment Data, details information on Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) products and services provided to Medicare beneficiaries via referrals through physicians and other healthcare professionals. This data covers 2013 and 2014.

The Medicare Durable Medical Equipment, Devices & Supplies by Referring Provider and Service dataset contains information on usage, payments and submitted charges organized by National Provider Identifier (NPI), Healthcare Common Procedure Coding System (HCPCS) code, and supplier rental indicator. Note: This full dataset contains more records than most spreadsheet programs can handle, which will result in an incomplete load of data. Use of a database or statistical software is required.

United States NHE: Durable Medical Equipment Expenditures (DME) data was reported at 54.416 USD bn in 2017. This records an increase from the previous number of 50.952 USD bn for 2016. United States NHE: Durable Medical Equipment Expenditures (DME) data is updated yearly, averaging 11.482 USD bn from Dec 1960 (Median) to 2017, with 58 observations. The data reached an all-time high of 54.416 USD bn in 2017 and a record low of 740.000 USD mn in 1960. United States NHE: Durable Medical Equipment Expenditures (DME) data remains active status in CEIC and is reported by Centers for Medicare & Medicaid Services . The data is categorized under Global Database’s United States – Table US.G084: National Health Expenditures.

Snapshot img

US Durable Medical Equipment Market Size 2024-2028

The US durable medical equipment market size is forecast to increase by USD 18.63 billion, at a CAGR of 5.6% between 2023 and 2028.

The Durable Medical Equipment (DME) market in the US is experiencing significant growth, driven by the expanding geriatric population and increasing patient preference for at-home medical treatment. The aging demographic trend is fueling demand for DME as the elderly population often requires more medical equipment and supplies to maintain their health and independence. Furthermore, the convenience and cost savings associated with at-home care are leading more patients to opt for DME solutions instead of institutionalized care. However, the DME market faces challenges that could hinder its growth. The high cost of durable medical equipment is a significant obstacle, making it difficult for some patients to afford necessary devices. Popular categories within the DME market include power scooters, oxygen equipment, walkers, wheelchairs, hospital beds, catheters, support braces, CPAP masks, and various other medical devices used in the treatment of conditions such as cancer and cardiac disorders.
Additionally, regulatory compliance and reimbursement policies pose challenges for market participants, requiring them to navigate complex regulations and ensure proper documentation to secure payment for their products and services. Companies seeking to capitalize on market opportunities must address these challenges by offering affordable pricing models, focusing on regulatory compliance, and providing exceptional customer service to ensure patient satisfaction and repeat business.

What will be the size of the US Durable Medical Equipment Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The Durable Medical Equipment (DME) market in the US is characterized by a focus on medical device safety, quality assurance systems, and regulatory compliance. Patient education materials and risk management strategies are essential components of ensuring safe and effective use of DME. Medical device testing and data privacy regulations play a critical role in maintaining trust with patients and healthcare providers. Wearable medical sensors and device interoperability are driving innovation in the DME sector, enabling better patient outcome measures and value-based healthcare. Medical equipment rental, including oxygen concentrators and home infusion therapy, offers cost-effective solutions for patients requiring long-term care.
Supply chain efficiency and infection control measures are key priorities for DME providers, with performance improvement initiatives and clinical documentation essential for maintaining regulatory compliance. Assistive technology, such as insulin pumps and wheelchair technology, is transforming the way patients manage their conditions at home. Medical device repair and cost-effectiveness studies are important considerations for healthcare providers seeking to optimize their DME investments. CPAP machines, enteral feeding pumps, bariatric equipment, and hospital bed systems are all subject to ongoing research and development to improve performance and patient satisfaction. Pressure ulcer prevention and medication adherence are critical areas of focus for DME providers, with equipment tracking systems and infection control measures essential for maintaining patient safety and quality of care.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product Type

  Monitoring and therapeutic devices
  Personal mobility devices
  Bathroom safety devices and medical furniture


End-user

  Hospitals and clinics
  Home healthcare
  Ambulatory surgical centers


Geography

  North America

    US

By Product Type Insights

The monitoring and therapeutic devices segment is estimated to witness significant growth during the forecast period.

In the dynamic and evolving landscape of medical devices, various sectors are experiencing significant growth and innovation. Orthopedic implants continue to advance, offering improved patient outcomes through enhanced materials and design. Data analytics in healthcare is revolutionizing diagnostics and treatment plans, enabling more personalized care. Sleep apnea therapy devices are gaining traction, addressing the growing prevalence of sleep disorders. Equipment lifecycle management is increasingly important, ensuring optimal performance and reducing healthcare costs. Diagnostic imaging devices, from MRI to CT scans, are essential tools in early detection and tre

About this Dataset

**Business to Consumer TCPA Compliant Leads You can use this leads for DME medicare A or B, Medicare Advantage and Med Supplement **Which industry is your product used for:Medicare AdvantageMed SuppDME-Med-BPharmaceutical SalesPPO / HMO/ MED BPain CreamDME-PPO (Durable Medical Equipment) **Information included on the leads Contacts name Contacts phone number (DNC scrubbed)

Email

These leads are low-income, in the best Dual Advantage areas in the US! These leads are a steal, I am selling these leads at a very reasonable price. I am sure that you will have benefits buying these products and will be back for more leads! Buy leads with amazing results! Leads are generated through client looking for a better health insurance plan and currently on Medicare Parts A and B. They opt-in or fill out a form on my websites Best TCPA leads you will find on the market right now. Med A and B leads looking for better health insurance plans and DME

Which industry is your product used for:Diabetic Supply DME Catheters DME Tele-Med DME Wheelchairs DME-HMO DME-Med-B DME-Posted DME-PPO (Durable Medical Equipment) Durable Medical Equipment (DME) Health Insurance Medical Devices Lead Generation Medicare Supplement Pain Cream TCPA Compliant Leads Best TCPA leads you will find on the market right now. Med A and B leads looking for better health insurance plans and DME What type of volume can you do per day? 10000 Aged Sales Leads A Day Describe in detail how your product is generated and sent over: Leads are generated through client looking for a better health insurance plan and currently on Medicare Parts A and B. They opt-in or fill out a form on my websites Why should someone pick your product? Best TCPA leads you will find on the market right now. Med A and B leads looking for better health insurance plans and DME Is your Data TCPA Compliant? Yes Once you accept an offer how soon can you start? ASAP how do i charge? Per Lead

Category

Health & Medicine

Keywords

health insurance,insurance,Email List,Email Leads,US Data

Row Count

24595

Price

$3000.00

This data package includes information about Medical Equipment Supplier Services for Healthcare Common Procedure Coding System (HCPCS) / Current Procedural Terminology (CPT) codes. It also comprises of datasets about Medically Unlikely Edits (MUEs) Outpatient Hospital Services as well as Medically Edits Practitioner Services HCPCS / CPT codes.

United States NHE: DME: Health Insurance (HI) data was reported at 25.236 USD bn in 2016. This records an increase from the previous number of 24.483 USD bn for 2015. United States NHE: DME: Health Insurance (HI) data is updated yearly, averaging 2.966 USD bn from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 25.236 USD bn in 2016 and a record low of 40.000 USD mn in 1961. United States NHE: DME: Health Insurance (HI) data remains active status in CEIC and is reported by Centers for Medicare & Medicaid Services . The data is categorized under Global Database’s USA – Table US.G083: National Health Expenditures.

The global Durable Medical Equipment (DME) for Home market, valued at $43.7 billion in 2025, is projected to experience robust growth, driven by several key factors. An aging global population, increasing prevalence of chronic diseases like diabetes and cardiovascular conditions, and rising demand for convenient and cost-effective healthcare solutions at home are significantly boosting market expansion. Technological advancements in DME, including the development of smaller, more user-friendly devices with improved connectivity and data monitoring capabilities, are further fueling market growth. The rising adoption of telehealth and remote patient monitoring (RPM) programs also contributes significantly, enabling healthcare providers to efficiently manage patients' conditions remotely using DME data. Growth is particularly strong in segments like blood glucose monitors and blood pressure monitors due to their widespread use in managing chronic diseases. However, high initial costs of certain DME, stringent regulatory approvals, and reimbursement challenges in some regions act as potential restraints. The market is segmented by application (retail pharmacies, hospital pharmacies, online) and by type of equipment (blood glucose monitors, blood pressure monitors, hearing aids, rehabilitation equipment, sleep apnea devices, and others). Competition is intense among established players such as Medtronic, Sonova, and Abbott Laboratories, alongside emerging companies offering innovative solutions. Geographically, North America and Europe currently hold the largest market share, but rapidly developing economies in Asia-Pacific are expected to witness significant growth in the coming years. The market's 7.2% CAGR from 2025-2033 indicates substantial future potential. This growth is expected to be relatively consistent across regions, although the pace may vary due to differing healthcare infrastructure and economic conditions. Online sales of DME are expected to grow significantly, driven by increasing e-commerce penetration and convenience. Further segmentation within equipment types will also emerge as technological innovation drives the development of new and specialized devices. Companies are focusing on strategic partnerships, mergers and acquisitions, and product diversification to maintain a competitive edge in this dynamic market. Future growth will be significantly shaped by factors such as government policies promoting home healthcare, technological advancements improving device usability and connectivity, and the evolving preferences of an aging population.

The Durable Medical Equipment (DME) for Home market is experiencing robust growth, projected to reach a market size of $43.7 billion in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 7.2% from 2025 to 2033. This expansion is driven by several key factors. The aging global population necessitates increased demand for home-based healthcare solutions, including mobility aids, respiratory equipment, and monitoring devices. Technological advancements in DME, such as smart sensors and telehealth integration, are enhancing patient care and convenience, further fueling market growth. Rising chronic disease prevalence, particularly diabetes and cardiovascular conditions, also contributes to elevated demand for home-based diagnostic and therapeutic devices. Increased government initiatives promoting home healthcare and reimbursement policies are creating favorable market conditions. Competitive landscape is shaped by a mix of established multinational corporations like Medtronic, Sonova, and Abbott Laboratories alongside specialized DME manufacturers. These companies are investing heavily in research and development to introduce innovative and user-friendly products, leading to heightened competition and market dynamism. However, certain restraints impact market expansion. High costs associated with advanced DME can hinder accessibility, particularly in developing economies. Stringent regulatory approvals and reimbursement processes can slow down product launches. Furthermore, concerns regarding data security and privacy related to connected DME devices need to be addressed. Despite these challenges, the long-term outlook for the home DME market remains positive, driven by the confluence of demographic shifts, technological innovations, and supportive policy environments. Market segmentation analysis, while not detailed here, would likely reveal varying growth rates across equipment categories and geographic regions, reflecting unique healthcare needs and market dynamics. Future growth strategies for companies in this sector should focus on innovation, affordability, and robust data security measures to ensure market leadership.

Data Overview: ASPR, in partnership with the Centers for Medicare and Medicaid Services (CMS), provide de-identified and aggregated Medicare beneficiary claims data at the state/territory, county, and ZIP code levels in the HHS emPOWER Map and this public HHS emPOWER REST Service. The REST Service includes aggregated data from the Medicare Fee-For-Service (Parts A&B) and Medicare Advantage (Part C) Programs for beneficiaries who rely on electricity-dependent durable medical equipment (DME) and cardiac implantable devices.

Data includes the following DME and devices: Cardiac devices (left, right, and bi-ventricular assistive devices
  (LVAD, RVAD, BIVAD) and total artificial hearts (TAH)), ventilators
  (invasive, non-invasive and oscillating vests), bi-level positive airway
  pressure device (BiPAP), oxygen concentrator, enteral feeding tube,
  intravenous (IV) infusion pump, suction pump, end-stage renal disease
  (ESRD) at-home dialysis, motorized wheelchair or scooter, and electric
  bed.



Purpose: Over 3 million Medicare beneficiaries rely on electricity-dependent
 medical equipment, such as ventilators, to live independently in their
 homes. Severe weather and other emergencies, especially those with long
 power outages, can be life-threatening for these individuals. The HHS
 emPOWER Map and public REST Service give every public health official,
 emergency manager, hospital, first responder, electric company, and
 community member the power to discover the electricity-dependent Medicare
 population in their state/territory, county, and ZIP Code.



Data Source: The REST Service’s data is developed from Medicare Fee-For-Service
  (Part A & B) (>33M 65+, blind, ESRD [dialysis], dual-eligible,
  disabled [adults and children]) and Medicare Advantage (Part C) (>21M
  65+, blind, ESRD [dialysis], dual-eligible, disabled [adults and
  children]) beneficiary administrative claims data. This data does not
  include individuals that are only enrolled in a State Medicaid Program.
  Note that Medicare DME are subject to insurance claim reimbursement caps
  (e.g. rental caps) that differ by type, so the DME may have different
  “look-back” periods (e.g. ventilators are 13 months and oxygen
  concentrators are 36 months).



ZIP Code Aggregation: Some ZIP Codes do not have specific geospatial boundary data (e.g.,
  P.O. Box ZIP Codes). To capture the complete population data, the HHS
  emPOWER Program identified the larger boundary ZIP Code (Parent) within
  which the non-boundary ZIP Code (Child) resides. The totals are added
  together and displayed under the parent ZIP Code.




Approved Data Uses: The public HHS emPOWER REST Service is approved for use by all partners
  and is intended to be used to help inform and support emergency
  preparedness, response, recovery, and mitigation activities in all
  communities.






Privacy Protections: Protecting the privacy of Medicare beneficiaries is an essential
  priority for the HHS emPOWER Program. Therefore, all personally
  identifiable information are removed from the data and numerous
  de-identification methods are applied to significantly minimize, if not
  completely mitigate, any potential for deduction of small cells or
  re-identification risk. For example, any cell size found between the
  range of 1 and 10 is masked and shown as 11.

The HME (Home Medical Equipment) and DME (Durable Medical Equipment) billing software market is experiencing robust growth, projected at a CAGR of 8.2% from 2019 to 2033. The market size in 2025 is estimated at $549 million. This expansion is fueled by several key drivers. Increasing demand for efficient billing solutions within the healthcare sector, coupled with the rising adoption of electronic health records (EHR) and the shift towards value-based care, are significantly impacting market growth. Furthermore, regulatory pressures to reduce administrative costs and improve billing accuracy are compelling HME and DME providers to adopt sophisticated billing software. The competitive landscape is dynamic, with key players such as Curasev, NikoHealth, Brightree, and others vying for market share through innovation in software features, integration with other healthcare systems, and enhanced customer support. The market segmentation likely includes features such as cloud-based vs. on-premise solutions, provider type (independent vs. large chains), and pricing models (subscription vs. one-time purchase). The trend toward cloud-based solutions, offering scalability and accessibility, is particularly noteworthy, alongside increased focus on data analytics and reporting capabilities within the software. While specific regional data is missing, we can infer substantial market penetration across North America and Europe, given the global nature of the HME/DME industry and the technological advancements in these regions. The continued growth of the HME and DME billing software market is expected to be driven by factors such as the increasing aging population, leading to higher demand for medical equipment, and the ongoing expansion of telehealth services. However, potential restraints might include the high initial investment costs for implementing new software, the need for extensive staff training, and the complexity of integrating the software with existing healthcare IT infrastructure. Despite these challenges, the long-term prospects for the market remain positive, driven by the increasing need for streamlined billing processes, improved revenue cycle management, and enhanced patient care. The market will likely see further consolidation as larger companies acquire smaller players and offer more comprehensive solutions. The focus will continue to be on user-friendliness, robust features, and seamless integration with other healthcare technologies.

This map image layer represents the U.S. Department of Health and Human Services (HHS) emPOWER Program, a partnership between ASPR and the Centers for Medicare and Medicaid Services, provides dynamic data and mapping tools to help communities protect the health of more than 4.1 million Medicare beneficiaries who live independently and rely on electricity-dependent medical equipment and health care servicesASPR, in partnership with the Centers for Medicare and Medicaid Services (CMS), provide de-identified and aggregated Medicare beneficiary claims data at the state/territory, county, and ZIP code levels in the HHS emPOWER Map and this public HHS emPOWER REST Service. The REST Service includes aggregated data from the Medicare Fee-For-Service (Parts A&B) and Medicare Advantage (Part C) Programs for beneficiaries who rely on electricity-dependent durable medical equipment (DME) and cardiac implantable devices. Data includes the following DME and devices: cardiac devices (left, right, and bi-ventricular assistive devices (LVAD, RVAD, BIVAD) and total artificial hearts (TAH)), ventilators (invasive, non-invasive and oscillating vests), bi-level positive airway pressure device (BiPAP), oxygen concentrator, enteral feeding tube, intravenous (IV) infusion pump, suction pump, end-stage renal disease (ESRD) at-home dialysis, motorized wheelchair or scooter, and electric bed. Purpose: Over 2.5 million Medicare beneficiaries rely on electricity-dependent medical equipment, such as ventilators, to live independently in their homes. Severe weather and other emergencies, especially those with long power outages, can be life-threatening for these individuals. The HHS emPOWER Map and public REST Service give every public health official, emergency manager, hospital, first responder, electric company, and community member the power to discover the electricity-dependent Medicare population in their state/territory, county, and ZIP Code. Data Source: The REST Service’s data is developed from Medicare Fee-For-Service (Part A & B) (>33M 65+, blind, ESRD [dialysis], dual-eligible, disabled [adults and children]) and Medicare Advantage (Part C) (>21M 65+, blind, ESRD [dialysis], dual-eligible, disabled [adults and children]) beneficiary administrative claims data. This data does not include individuals that are only enrolled in a State Medicaid Program. Note that Medicare DME are subject to insurance claim reimbursement caps (e.g. rental caps) that differ by type, so the DME may have different “look-back” periods (e.g. ventilators are 13 months and oxygen concentrators are 36 months). ZIP Code Aggregation: Some ZIP Codes do not have specific geospatial boundary data (e.g., P.O. Box ZIP Codes). To capture the complete population data, the HHS emPOWER Program identified the larger boundary ZIP Code (Parent) within which the non-boundary ZIP Code (Child) resides. The totals are added together and displayed under the parent ZIP Code. Approved Data Uses: The public HHS emPOWER REST Service is approved for use by all partners and is intended to be used to help inform and support emergency preparedness, response, recovery, and mitigation activities in all communities. Privacy Protections: Protecting the privacy of Medicare beneficiaries is an essential priority for the HHS emPOWER Program. Therefore, all personally identifiable information are removed from the data and numerous de-identification methods are applied to significantly minimize, if not completely mitigate, any potential for deduction of small cells or re-identification risk. For example, any cell size found between the range of 1 and 10 is masked and shown as 11.HHS emPOWER Program Executive SummaryHHS emPOWER Program Informational Power Point.

Incidence and adjusted hazard ratio of NPDR, PDR, and DME according to sex, age, and comorbidity, compared between diabetes patients with and without diabetic nephropathy.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

Demographics and comorbidities of diabetes mellitus patients with and without diabetic nephropathy.

Hazard ratios of outcomes according to sex, age, and comorbidity, obtained using univariate and multivariate Cox regression models.

Prior Authorization Software Market size was valued at USD 2.76 Billion in 2024 and is projected to reach USD 5.99 Billion by 2032, growing at a CAGR of 10.2% during the forecast period 2026 to 2032. • Complexity in Reimbursement Processes: The increasing complexity of reimbursement processes is addressed by prior authorization software, which helps simplify workflows, reduce errors, and ensure that administrative tasks are handled more efficiently and accurately.• Demand for Operational Efficiency: Software solutions are adopted to streamline administrative tasks, optimize resource management, and improve workflow efficiency, allowing healthcare providers to focus more on patient care rather than manual paperwork.• Regulatory Compliance Requirements: Prior authorization software is utilized to ensure compliance with healthcare regulations like HIPAA, ensuring secure data handling and protection of patient privacy while adhering to industry standards and legal requirements.• Patient-Centric Care: Patient experiences are improved through faster processing of treatment approvals by prior authorization software, which reduces delays and ensures timely access to necessary services, leading to better patient satisfaction.• Integration with Healthcare Ecosystem: Prior authorization software is integrated with existing healthcare systems like EHRs and payer platforms, facilitating seamless data exchange, enhancing communication, and improving automation in the authorization process.

South Korea Exports: ICT: IAB: ME: Diagnosis and Medical Equipment (DME) data was reported at 186,640,276.000 USD in Mar 2025. This records an increase from the previous number of 178,014,434.000 USD for Feb 2025. South Korea Exports: ICT: IAB: ME: Diagnosis and Medical Equipment (DME) data is updated monthly, averaging 68,067,307.000 USD from Jan 1996 (Median) to Mar 2025, with 351 observations. The data reached an all-time high of 192,046,777.000 USD in Dec 2024 and a record low of 2,355,207.000 USD in Jan 1997. South Korea Exports: ICT: IAB: ME: Diagnosis and Medical Equipment (DME) data remains active status in CEIC and is reported by Statistics Korea. The data is categorized under Global Database’s South Korea – Table KR.JA064: Trade Statistics: Export: Information & Communication Technology Industry.

The Global Healthcare Equipment Leasing Market Size Was Worth USD 108.51 Billion in 2022 and Is Expected To Reach USD 348.43 Billion by 2030, CAGR of 15.70%.